These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 16446012

  • 1. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS, Vyas SP.
    Vaccine; 2006 May 08; 24(19):4201-11. PubMed ID: 16446012
    [Abstract] [Full Text] [Related]

  • 2. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
    Thomas C, Gupta V, Ahsan F.
    Int J Pharm; 2009 Sep 08; 379(1):41-50. PubMed ID: 19524654
    [Abstract] [Full Text] [Related]

  • 3. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V, Jain V, Sudheesh MS, Jaganathan KS, Murthy PK, Kohli DV.
    Int J Pharm; 2011 Apr 15; 408(1-2):50-7. PubMed ID: 21291968
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.
    Pandey RS, Dixit VK.
    J Drug Target; 2010 May 15; 18(4):282-91. PubMed ID: 19958131
    [Abstract] [Full Text] [Related]

  • 6. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK, Tomar P, Sharma V, Dixit VK.
    Vaccine; 2011 Nov 08; 29(48):9026-37. PubMed ID: 21939718
    [Abstract] [Full Text] [Related]

  • 7. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS, Singh P, Prabakaran D, Mishra V, Vyas SP.
    J Pharm Pharmacol; 2004 Oct 08; 56(10):1243-50. PubMed ID: 15482638
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A, Katare OP, Singh B, Vyas SP.
    Int J Pharm; 2010 Jan 29; 385(1-2):47-52. PubMed ID: 19835938
    [Abstract] [Full Text] [Related]

  • 15. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.
    Brandhonneur N, Loizel C, Chevanne F, Wakeley P, Jestin A, Le Potier MF, Le Corre P.
    Int J Pharm; 2009 May 21; 373(1-2):16-23. PubMed ID: 19429284
    [Abstract] [Full Text] [Related]

  • 16. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
    Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK.
    Eur J Pharm Sci; 2008 Apr 23; 33(4-5):424-33. PubMed ID: 18359615
    [Abstract] [Full Text] [Related]

  • 17. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
    Feng L, Zhou XJ, Wang SC, Jiang Y, Qi XR.
    Yao Xue Xue Bao; 2006 Feb 23; 41(2):132-7. PubMed ID: 16671543
    [Abstract] [Full Text] [Related]

  • 18. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.
    Gupta PN, Khatri K, Goyal AK, Mishra N, Vyas SP.
    J Drug Target; 2007 Dec 23; 15(10):701-13. PubMed ID: 18041638
    [Abstract] [Full Text] [Related]

  • 19. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization.
    Gupta PN, Vyas SP.
    Colloids Surf B Biointerfaces; 2011 Jan 01; 82(1):118-25. PubMed ID: 20843665
    [Abstract] [Full Text] [Related]

  • 20. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D, Jaganathan KS.
    Drug Deliv; 2016 Jan 01; 23(1):185-94. PubMed ID: 24825494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.